Sofosbuvir–velpatasvir: A single-tablet treatment for hepatitis C infection of all genotypes-Reference-Cited by-同舟云学术

Sofosbuvir–velpatasvir: A single-tablet treatment for hepatitis C infection of all genotypes

Published:2017-07-15 Issue:14 Volume:74 Page:1045-1052
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Miller Misty M.¹

Affiliation:

1. Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/74/14/1045/28336129/ajhp1045.pdf

Reference29 articles.

1. An overview of HCV molecular biology, replication, and immune responses;Ashfaq;Virol J.,2011

2. Recent advances and future directions in the management of hepatitis C infections;Belousova;Pharmacol Ther.,2015

3. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology.,2015

4. American Association for the Study of Liver Diseases, Infectious Diseases Society of America, International Antiviral Society–USA. HCV guidance: recommendations for testing, managing, and treating hepatitis C. www.hcvguidelines.org (accessed 2016 Oct 27).

5. Is genotype 3 of the hepatitis C virus the new villain?;Goossens;Hepatology.,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C prevalence and cascade of care among patients in the decentralised opioid agonist therapy programme of the canton of St Gallen, Switzerland: a cross-sectional study;Swiss Medical Weekly;2024-02-29

2. Simplified Test-to-Treat Strategy for Hepatitis C in Thailand: The Phetchabun Model;The Journal of Infectious Diseases;2023-09-13

3. An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA;PLOS ONE;2023-06-29

4. Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis;Medicine;2022-10-21

5. Utilization of HCV Viremic Kidneys with Genotyping/Subtyping-Free Sofosbuvir/Velpatasvir Treatment Strategy: Experience from China;BioMed Research International;2022-07-30